Phosphodiesterase Inhibitors Prevent Endothelin-1-Induced Vasoconstriction, Bronchoconstriction, and Thromboxane Release in Perfused Rat Lung
- 3 February 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 231 (1) , 22-25
- https://doi.org/10.1006/bbrc.1996.6042
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- PDE isoenzymes as targets for anti-asthma drugsEuropean Respiratory Journal, 1995
- Cyclic nucleotides and phosphodiesterases and airway functionEuropean Respiratory Journal, 1995
- Cytokines, Phagocytes, and PentoxifyllineJournal of Cardiovascular Pharmacology, 1995
- Endothelin-Induced Bronchoconstriction in Perfused Rat Lungs Is Partly Mediated by ThromboxaneJournal of Cardiovascular Pharmacology, 1995
- The Type III Phosphodiesterase Inhibitor Milrinone and Type V PDE Inhibitor Dipyridamole Individually and Synergistically Reduce Elevated Pulmonary Vascular ResistancePulmonary Pharmacology, 1994
- An improved setup for the isolated perfused rat lungJournal of Pharmacological and Toxicological Methods, 1994
- Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchusBritish Journal of Pharmacology, 1993
- Effects of selective phosphodiesterase inhibitors on isolated coronary, lung and renal arteries from man and ratActa Physiologica Scandinavica, 1991
- Comparison of the effects of intra‐arterial and aerosol administration of endothelin‐1 (ET‐1) in the guinea‐pig isolated lungBritish Journal of Pharmacology, 1991
- cAMP dependent inhibition of thromboxane A2, prostacyclin and PGF2α synthesis in mouse hepatocytesProstaglandins, 1988